2022. Cytidine-phosphate-guanosine oligodeoxynucleotides in combination with CD40 ligand decrease periodontal inflammation and alveolar bone loss in a TLR9-independent manner. Journal of Applied Oral Science. 26, (Sep. 2022), e20170451.